Decreasing Nightmares in Adults With Narcolepsy

Part of paid clinical trials in Salt Lake City, Utah.

Sponsor
University of Utah
Study ID
NCT06383806
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Narcolepsy
  • Narcolepsy Type 1
  • Narcolepsy With Cataplexy
  • Narcolepsy Without Cataplexy
  • Nightmare
  • Nightmare Disorder With Associated Other Sleep Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Imagery Rehearsal Therapy (IRT) — BEHAVIORAL
    The intervention will consist of 7 therapy sessions (once per week for 7 weeks) which will be delivered via videoconference. During the sessions, participants will learn techniques for managing and changing nightmares.

Study Details

The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will complete three assessments. Half of the participants will receive the treatment after the first assessment, and half will receive it after the second assessment. Romantic partners of participants with narcolepsy will also be eligible to enroll in the study. Partners will complete three assessments but will not participate in the treatment.

Key Dates

Start date
Apr 1, 2026
Status verified
Mar 2026
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
80 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment
    The Treatment arm will receive the intervention immediately following the first assessment.
  • Other: Waitlist
    The Waitlist arm will undergo a waiting period following the first assessment and then will receive the treatment after the second assessment.

Primary Outcome Measure

Disturbing Dream and Nightmare Severity Index (DDNSI) [ Time Frame: Completed at each of the three assessments (baseline, 10 weeks, 19 weeks) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of UtahSalt Lake CityUtah84108
Jennifer Mundt, PhD
[email protected]
801-646-8287

Find similar trials in Salt Lake City, UT

By research site
University of Utah· Salt Lake City, UT

Related Studies